Table 3.
Goal | Before intervention | After intervention | p Value |
To enable safe drugs to be identified | 36 (43.9) | 46 (56.1) | 0.02 |
To measure the incidence of ADR | 39 (47.6) | 57 (69.5) | <0.001 |
To identify factors which might predispose to ADR | 35 (42.7) | 58 (70.7) | <0.001 |
To identify previously unrecognised ADRs | 56 (68.3) | 70 (85.4) | <0.001 |
To compare ADRs for drugs in similar therapeutic classes | 36 (43.9) | 52 (63.4) | <0.001 |
To compare ADRs of same drug from different drug companies | 44 (53.7) | 44 (53.7) | 1 |
ADRs, adverse drug reactions.